| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.64 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.42 | 0.0008 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.23 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.22 | 0.1 |